205 results on '"Liu, Zhuyun"'
Search Results
2. Crystal structure of 14-(R)-(2′-cyano-phenoxy)-3,19-diacetyl andrographolide, C31H37NO7
3. Anti-metastatic effects of AGS-30 on breast cancer through the inhibition of M2-like macrophage polarization
4. A SH3b domain-containing peptidoglycan recognition protein from Magallana gigas with broad recognition spectrum
5. Biophysical and biochemical characterization of a recombinant Lyme disease vaccine antigen, CspZ-YA
6. Exploration of novel hexahydropyrrolo[1,2-e]imidazol-1-one derivatives as antiviral agents against ZIKV and USUV
7. Design, synthesis, and antifungal activity of hydrazone Schiff bases containing cinnamaldehyde moieties.
8. Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
9. The new andrographolide derivative AGS-30 induces apoptosis in human colon cancer cells by activating a ROS-dependent JNK signalling pathway
10. DNA binding protein CgIkaros-like regulates the proliferation of agranulocytes and granulocytes in oyster (Crassostrea gigas)
11. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
12. A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis
13. A novel radiomics–platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients
14. The effect of remote ischemic postconditioning on autonomic function in patients with acute ischemic stroke: A Randomized Controlled Trail
15. Effects of Tai Chi exercise on cardiovascular disease risk factors and quality of life in adults with essential hypertension: A meta-analysis
16. Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate
17. Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
18. Crystal structure of 14-(R)-(2′-cyano-phenoxy)-3,19-diacetyl andrographolide, C31H37NO7.
19. Andrographolide derivative ameliorates dextran sulfate sodium-induced experimental colitis in mice
20. Synthesis, evaluation and in silico studies of novel BRD4 bromodomain inhibitors bearing a benzo[d]isoxazol scaffold
21. A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
22. Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis
23. Transferring Luminex® cytokine assays to a wall-less plate technology: Validation and comparison study with plasma and cell culture supernatants
24. Incidence and Risk Factors for Hypotension after Carotid Artery Stenting: Systematic Review and Meta-analysis
25. Incidence and risk factors for hypotension after carotid artery stenting: Systematic review and meta-analysis.
26. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice
27. Frailty in stroke adults aged 60 and over: A cross-sectional survey from Chinese community.
28. CspZ FH-Binding Sites as Epitopes Promote Antibody-Mediated Lyme Borreliae Clearance
29. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
30. Classification of Alzheimer’s Disease Based on Abnormal Hippocampal Functional Connectivity and Machine Learning
31. Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis
32. From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access.
33. Effect of 1,25-Dihydroxyvitamin D3 on Stem Cells from Human Apical Papilla: Adhesion, Spreading, Proliferation, and Osteogenic Differentiation
34. Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine Candidate
35. A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
36. Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
37. Facile Synthesis of New Imidazo[4',5':4,5]benzo[1,2-d] isoxazol-6-one Derivatives and In Silico Studies of Their Drug-like Profiles
38. SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
39. The small regulatory RNA FasX controls pilus expression and adherence in the human bacterial pathogen group A Streptococcus
40. A Novel Radiomics-Platelet Nomogram for the Prediction of Gastroesophageal Varices Needing Treatment in Cirrhotic Patients
41. A Multi-Organ Fusion and LightGBM Based Radiomics Algorithm for High-Risk Esophageal Varices Prediction in Cirrhotic Patients
42. Process Development and Scale-up Optimization of the SARS-CoV-2 Receptor Binding Domain-Based Vaccine Candidate, RBD219-N1C1
43. Genetic Modification to Design a Stable Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain as a COVID-19 Vaccine Candidate
44. SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice
45. Effect of Rare Earth Metal (RE = La, Pr, Nd, Y) Doping on Co–Ce Composite Oxide and Its Application in Catalytic Combustion of Chlorobenzene
46. The group A Streptococcus small regulatory RNA FasX enhances streptokinase activity by increasing the stability of the ska mRNA transcript
47. Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection
48. Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis (Volume 11, Number 3)
49. Synthesis of Benzyl Phenol from Benzyl Aryl Ether by Polyphosphoric Acid-Catalyzed Benzyl Rearrangement
50. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 + T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.